Recent Reports Of Side Effects Related To Popular GI Medications May Make Manufacturers Sick To their Stomachs
Recent studies in several highly regarded medical journals have linked some of the most popular medications on the market for farily common gastrointestinal issues to an increased risk of developing kidney disease. With over $7 billion in annual sales, Proton Pump Inhibitors (PPIs) are one the most prescribed classes of drugs ever. Some of the most popular brands of PPIs are:
Making this problem potentially more widespread, PPIs are now available in both prescription and over-the-counter form. And consequently, advertisements for the most popular PPIs are popping up all over television and radio stations, claiming that by taking one pill a day users can be heartburn free. PPIs have been used to treat a variety of common gastrointestinal ailments, including:
- Gastroesophageal Reflux Disease (GERD)
- Stomach ulcers
- Inflammation of the esophagus
However, the regular, prolonged use of these common medications may not be as safe as once thought. Recent studies suggest that the use of PPIs may increase the risk of damage to the kidneys by as much as 20% to 50%. Injuries that have been associated with PPI use include:
- Acute renal failure
- Chronic kidney disease
- Interstitial nephritis
- End stage renal disease
Damage to the kidneys can result in a gradual loss of kidney function over the course of several months, or even years. Because the symptoms associated with decreased kidney function may not even be noticeable at first, kidney disease may go untreated and develop into end-stage renal disease. Symptoms associated with a loss of kidney function may include:
- A change in urine output
- Fluid retention, especially in the legs and feet
- Weight gain
A decline in kidney function can have a significant impact on someone’s health. The kidneys play a key role in removing waste from the blood while retaining vital nutrients needed by the body. As kidney function declines, the levels of waste and toxins can build up in the body can result in damage to not only the kidney, but other vital organs as well.
With other treatment alternatives available, current users of PPIs may want to consult with prescribing physicians or pharmacists about the best treatment option for their particular condition, or if they experience symptoms related to kidney failure.
The postings on this blog were created for general informational purposes only and do not constitute legal advice or a solicitation to provide legal services. Although we attempt to ensure that the postings are complete, accurate, and current as of the time of publication, we assume no responsibility for their completeness, accuracy, or timeliness. The information in this blog is not intended to create, and receipt of it does not constitute, a lawyer-client relationship. Readers should not act upon this information without seeking professional legal counsel.
This blog may contain links to independent third party websites and services, including social media. We provide these links for your convenience, and you access them at your own risk. We have no control over and do not monitor the content or policies (including privacy policies) of these third-party websites and have no responsibility for, and no liability with respect to, their content, accuracy, or reliability. Unless expressly stated, we do not endorse any of the linked websites or any product, service, or publication referenced herein or therein. We will remove a link to any site from this blog upon request of the linked entity.
We grant permission to readers to link to this blog so long as this blog is not misrepresented. This site is not sponsored or associated with any other site unless so identified.
If you wish for Wilentz, Goldman & Spitzer, P.A., to consider representing you, please obtain contact information from the Contact Us area of this blog or go to the firm’s website at www.wilentz.com. One of our lawyers will be happy to discuss the possibility of representation with you. However, the authors of Wilentz blogs are licensed only in New Jersey and/or New York and do not wish to represent anyone who viewed this site in a state where the site fails to comply with all laws and ethical rules of that state.